Page 307 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 307

298        ACID-BASE DISORDERS


            DIAGNOSIS AND CLINICAL FEATURES                      TREATMENT OF RESPIRATORY
            OF RESPIRATORY ALKALOSIS                             ALKALOSIS
            It is difficult to attribute specific clinical signs to respira-  Treatment should be directed towards relieving the
            tory alkalosis in the dog and cat. The clinical signs usually  underlying cause of the hypocapnia; no other treatment
            are caused by the underlying disease process and not by  is effective. Respiratory alkalosis severe enough to cause
            the respiratory alkalosis itself. However, in humans, head-  clinical consequences for the animal is uncommon.
            ache, light-headedness, confusion, paresthesias of the  Hypocapnia itself is not a major threat to the well being
            extremities, tightness of the chest, and circumoral numb-  of the patient. Thus the underlying disease responsible for
                                                         23,1
            ness have been reported in acute respiratory alkalosis.  hypocapnia should receive primary therapeutic attention.
            In any case, clinical signs in small animals are uncommon
            due to efficient metabolic compensation and tachypnea  DYSPNEA
            may be the only clinical abnormality found, especially
            with chronic hypocapnia.                             In small animal practice, dyspnea is an important clinical
               If the pH is greater than 7.6 in respiratory      sign associated with acute or severe respiratory dysfunc-
            alkalosis, neurologic, cardiopulmonary, and metabolic  tion and abnormal acid-base regulation. In animals, dys-
                                1
            consequences may arise. Such a pH can only be achieved  pnea is defined as difficult or labored breathing.
            in acute respiratory alkalosis before renal compensation  However, dyspnea in humans is further described as an
            ensues. Alkalemia results in arteriolar vasoconstriction  unpleasant sensory experience of breathing discomfort
            that can decrease cerebral and myocardial perfusion. In  or “pain.” With the recent advances in veterinary pain rec-
            addition, hyperventilation (PCO 2 <25 mm Hg) causes  ognition and management, it is appropriate to assume
            decreased cerebral blood flow, potentially resulting in  veterinary  patients  have  similar  negative  sensory
            clinical signs such as confusion and seizures.       experiences associated with disorders that result in dys-
               Hypocapnia decreases blood pressure and cardiac out-  pnea in humans. There are at least three types of dyspnea
            put in anesthetized but not awake subjects, possibly  that are pertinent to veterinary patients: air hunger,
            because anesthetics blunt reflex tachycardia. For example,  increased work of breathing, and thoracic tightness*.
            in anesthetized dogs, acute hypocapnia decreased blood  Air hunger results from an imbalance in the perception
            pressure as a result of reduced cardiac output together  of an increased drive to breathe from chemoreceptors
            with an ineffective increase in total peripheral resistance  (e.g., hypoxemia and hypercapnia) relative to the afferent
            and no change in heart rate. 39,52  Although alkalemia  signaling from stretch receptors in the thoracic cavity and
            exerts a small positive inotropic effect on the isolated  lungs. 51  Although air hunger does not require abnormal
            heart, alkalemia also predisposes to refractory supraven-  arterial concentrations of oxygen or carbon dioxide, it is
            tricular and ventricular arrhythmias, especially in patients  the balance of the patient’s actual alveolar ventilation
            with preexisting cardiac disease. 1                  compared with the ventilation needed to maintain normal
               Acute alkalemia shifts the oxygen-hemoglobin dissoci-  acid-base regulation of the patient that determines if dys-
            ation curve to the left, reducing the release of oxygen to  pnea occurs. A second type of dyspnea occurs with an
            the tissues by increasing affinity of hemoglobin for oxy-  increased work or effort of breathing. Increased respira-
            gen 31  (see Figure 11-3). However, chronic alkalemia  tory pressures generated to breathe in the face of
            negates this effect by increasing the concentration of  decreased pulmonary compliance, airway obstruction,
            2,3-DPG in red cells. 30,23,66                       or alterations in respiratory muscle length result in dys-
               Hypokalemia may occur due to the translocation of  pnea. 21,71  A common example of this type is seen in
            potassium into cells and renal and extrarenal losses in  dynamic upper airway obstructions in which cognitive
            patients with acute respiratory alkalosis. 23,30,66  In  awareness of the inability to breathe can reach distressing
            anesthetized, hyperventilated dogs, potassium is expected  levels. Lastly, in humans, and presumably in animals,
            to decrease 0.4 mEq/L for each 10-mm Hg decrease in  asthmatic chest tightness results in dyspnea secondary
            PCO 2 . 52  Similar changes (0.6 mEq/L for each 10-mm  to bronchoconstriction. The primary afferent signals
            Hg decrease in PCO 2 ) were observed in awake dogs with  responsible for this type of dyspnea are generated from
            acute respiratory acidosis induced by hypoxemia 32  or by  intrapulmonary afferent receptors and not respiratory
            simulating a high altitude environment (30,000 feet). 72  muscle afferents. 9,45
            Hypokalemia can result in neuromuscular weakness, sen-  Treatment specifically directed at relieving dyspneic
            sitization to digitalis-induced arrhythmias, polyuria, and  sensations associated with respiratory disorders is chal-
            increased ammonia production that amplifies the effects  lenging. Although therapy should initially be directed
                                    1
            of hepatic encephalopathies. However, the hypokalemia  at removing the inciting cause, newer treatments such
            induced by respiratory alkalosis is mild and short-lived.
            Hypokalemia is not present in patients with chronic
            respiratory alkalosis. 2,22,25
                                                                 *For review see Mellema, 2008. 48
   302   303   304   305   306   307   308   309   310   311   312